Edition:
United Kingdom

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

5.76USD
10 Dec 2018
Change (% chg)

$0.12 (+2.13%)
Prev Close
$5.64
Open
$5.65
Day's High
$5.77
Day's Low
$5.50
Volume
36,205
Avg. Vol
93,169
52-wk High
$20.17
52-wk Low
$5.50

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.634
Jun '18 0.00 -0.595
Mar '18 0.00 -0.460
FY 2017 Dec '17 0.00 -1.606
Sep '17 0.00 -0.564
Jun '17 0.00 -0.472
Mar '17 0.00 -0.419
FY 2016 Dec '16 0.00 -0.361
Sep '16 0.00 -0.415
Jun '16 0.00 -0.423
Mar '16 0.00 -0.226
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 0.00 0.00 0.00 13.00
Quarter Ending Mar-19 3 2.03 2.70 1.30 16.90
Year Ending Dec-18 5 0.00 0.00 0.00 0.00
Year Ending Dec-19 5 18.61 25.30 11.00 57.99
Earnings (per share)
Quarter Ending Dec-18 5 -0.52 -0.45 -0.60 -0.61
Quarter Ending Mar-19 4 -0.64 -0.43 -0.78 -0.66
Year Ending Dec-18 5 -2.20 -2.11 -2.30 -1.81
Year Ending Dec-19 5 -2.35 -2.03 -2.84 -1.76
LT Growth Rate (%) 1 -61.50 -61.50 -61.50 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.36 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta -- 0.91 0.90
Price to Sales (TTM) -- 116.41 5.77
Price to Book (MRQ) -- 15.60 5.12
Price to Tangible Book (MRQ) 49.92 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions 24.74 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago -- 90.38 5.80
Sales - 5 Yr. Growth Rate -- 31.32 10.19
EPS (MRQ) vs Qtr. 1 Yr. Ago -11.50 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago -57.16 -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate -- 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.98 2.28
Current Ratio (MRQ) 3.55 5.42 3.11
LT Debt to Equity (MRQ) 68.25 33.58 11.47
Total Debt to Equity (MRQ) 88.50 35.41 15.63
Interest Coverage (TTM) -32.37 -152.89 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.87 54.21
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -506.71 11.83
Operating Margin (TTM) -- -728.63 4.90
Operating Margin - 5 Yr. Avg. -- -526.19 7.44
Pre-Tax Margin (TTM) -- -694.90 5.91
Pre-Tax Margin - 5 Yr. Avg. -- -531.06 7.89
Net Profit Margin (TTM) -- -696.67 2.16
Net Profit Margin - 5 Yr. Avg. -- -534.50 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 25,687,363 898,926,015
Net Income/Employee (TTM) -1,552,280 2,194,067 106,550,787
Receivable Turnover (TTM) -- 18.46 5.94
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) -- 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.11 11.50
Return on Assets - 5 Yr. Avg. -- 2.88 12.67
Return on Investment (TTM) -- 0.28 15.02
Return on Investment - 5 Yr. Avg. -- 1.84 16.45
Return on Equity (TTM) -- 0.94 16.60
Return on Equity - 5 Yr. Avg. -- 2.30 17.56
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % -98.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kala Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -11.02 -14.09 42 57
13 Week -- -- -- 62
26 Week -- -- -- 81
52 Week -- -- -- 47
YTD -- -- -- 60
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 68.23%
# of Holders: 107
Total Shares Held: 23,059,267
3 Mo. Net Change: 1,286,540
# New Positions: 22
# Closed Positions: 22
# Increased Positions: 50
# Reduced Positions: 44
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.